What the ‘One Nation, Overcharged’ Campaign Aims to Achieve
One Nation, Overcharged, a campaign backed by the Robert Wood Johnson Foundation, launched to raise awareness of rising healthcare costs.
Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer
Ona Therapeutics’ antibody drug conjugates come from a platform technology that discovers novel antigens intended to enable the therapies to overcome drug resistance. The Spain-based startup’s lead ADC is on track to begin clinical testing in breast cancer.
CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery
CereVasc raised $85 million in Series C funding to advance its minimally invasive eShunt system, which aims to treat hydrocephalus without traditional brain shunt surgery. The company is preparing for a pivotal trial completion and FDA submission in 2027.
Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices
MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, co-hosts of the Debunked Podcast, discussed the impact of Marty Makary’s resignation from the FDA, among other topics.
The Generational Inversion in Employer Health Costs That Most CFOs Aren’t Seeing
Millennials and Gen Z are more likely to engage earlier, seek care proactively, and continue treatment over time. A mental health diagnosis is more likely to represent active management, not a late-stage recognition of a problem that has already compounded.